Evidence map›Paper›PMID 25918555›Full record

ArticleGenome medicine2015

ClinSeK: a targeted variant characterization framework for clinical sequencing.

Wanding Zhou, Hao Zhao, Zechen Chong, Routbort J Mark, Agda K Eterovic, Funda Meric-Bernstam, Ken Chen

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Big Data Analytics for Genomic Medicine.International journal of molecular sciences · 2017
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wanding ZhouDepartment of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Hao ZhaoDepartment of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Zechen ChongDepartment of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Routbort J MarkDepartment of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Agda K EterovicDepartment of Systems Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA ; Institute of Personalized Cancer Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Funda Meric-BernstamInstitute of Personalized Cancer Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA ; Department of Investigational Cancer Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Ken ChenDepartment of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI MILLS, GORDON B. · 2004 to 2014
$27.1M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Delineating Heterogeneous Structural Complexity in Cancer GenomesR01CA172652 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHEN, KEN · 2013 to 2016
$1.4M
Informatics to enable routine personalized cancer therapyU01CA180964 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BERNSTAM, ELMER V., MERIC-BERNSTAM, FUNDA · 2013 to 2015
$964k
NCATS NIH HHS UL1 TR000371NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA172652NCI NIH HHS U01 CA180964NCI NIH HHS U54 CA112970
6 · The paper itself

Abstract

Applying genomics to patient care demands sensitive, unambiguous and rapid characterization of a known set of clinically relevant variants in patients' samples, an objective substantially different from the standard discovery process, in which every base in every sequenced read must be examined. Further, the approach must be sufficiently robust as to be able to detect multiple and potentially rare variants from heterogeneous samples. To meet this critical objective, we developed a novel variant characterization framework, ClinSeK, which performs targeted analysis of relevant reads from high-throughput sequencing data. ClinSeK is designed for efficient targeted short read alignment and is capable of characterizing a wide spectrum of genetic variants from single nucleotide variation to large-scale genomic rearrangement breakpoints. Applying ClinSeK to over a thousand cancer patients demonstrated substantively better performance, in terms of accuracy, runtime and disk storage, for clinical applications than existing variant discovery tools. ClinSeK is freely available for academic use at http://bioinformatics.mdanderson.org/main/clinsek.

Identifiers

PMID25918555
PMCPMC4410453
OpenAlexW2171543834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.